Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt · Delayed Price · Currency is EGP 3.380
-0.020 (-0.59%)
At close: Oct 22, 2025
EGX:MCRO Revenue
Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 227.15M EGP in the quarter ending June 30, 2025, with 137.32% growth. This brings the company's revenue in the last twelve months to 776.26M, up 125.64% year-over-year. In the year 2024, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 519.97M, down -1.15%.
Revenue (ttm)
776.26M
Revenue Growth
+125.64%
P/S Ratio
2.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 519.97M | -6.04M | -1.15% |
| Dec 31, 2023 | 526.01M | -203.61M | -27.91% |
| Dec 31, 2022 | 729.61M | 135.35M | 22.78% |
| Dec 31, 2021 | 594.26M | 163.76M | 38.04% |
| Dec 31, 2020 | 430.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| El Sewedy Electric Company | 253.16B |
| Commercial International Bank Egypt (CIB) S.A.E. | 111.86B |
| Telecom Egypt Company | 94.68B |
| Qatar National Bank | 50.63B |
| Talaat Moustafa Group Holding | 50.04B |
| Egypt Aluminum | 43.18B |
| Eastern Company S.A.E | 34.08B |
| Misr Fertilizer Production Company | 23.05B |